Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Abstract

Liver metastases from breast cancer (LMBC) are typically considered to indicate systemic disease spread and patients are most often offered systemic palliative treatment only. However, retrospective studies suggest that some patients may have improved survival with local treatment of their liver metastases compared to systemic therapy alone. In the absence… (More)
DOI: 10.1186/s12885-015-1499-z

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Seidensticker2015LocallyAT, title={Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)}, author={Max Seidensticker and Benjamin Garlipp and Sophia Scholz and K. Mohnike and Felix Popp and Ingo Guenter Steffen and Ricarda Seidensticker and Patrick Stuebs and Maciej Pech and Maciej Janusz Powerski and Peter Ha\ss and Serban-Dan Costa and Holger Amthauer and Christiane J Bruns and Jens Ricke}, booktitle={BMC Cancer}, year={2015} }